Literature DB >> 7494273

Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter.

I K Ruf1, D R Rawlins.   

Abstract

The transition from latency to lytic Epstein-Barr virus replication is dependent on the Epstein-Barr virus BZLF1 gene product. Genetic and biochemical attempts to link cellular second-messenger signaling pathways that trigger this transition with the subsequent viral gene cascade have identified functional elements within the BZLF1 promoter (Zp) that appear to bind undefined cellular transcription factors. One of these previously identified sites, ZII, has homology to consensus AP-1 and CREB binding sites, implying a role for these factors in the inductive process. We have identified and characterized ZIIBC, a ZII site binding complex that is distinct from the factors previously proposed to bind this site. Active ZIIBC was found to be present in both uninduced and chemically induced cell extracts at approximately equivalent concentrations. Analysis of the DNA sequence requirements for the binding of ZIIBC to the ZII site shows that sequences homologous to AP-1 and CREB consensus sites are necessary but not sufficient for complex formation. Although the components of ZIIBC that directly contact DNA were found to be of the same molecular masses (26 and 36 kDa) in both uninduced and chemically induced cell extracts, a slight mobility difference between DNA-protein complexes formed by these two types of extracts is observable and indicates that ZIIBC is directly affected by chemical induction. The effects of ZIIBC binding to the ZII site on expression from Zp were evaluated, and they suggest that ZIIBC plays a critical role in the regulation of Zp expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494273      PMCID: PMC189705     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Negative regulation of the BZLF1 promoter of Epstein-Barr virus.

Authors:  E A Montalvo; Y Shi; T E Shenk; A J Levine
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.

Authors:  T Hai; T Curran
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

3.  Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity.

Authors:  W J Boyle; T Smeal; L H Defize; P Angel; J R Woodgett; M Karin; T Hunter
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

4.  The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper.

Authors:  T Kouzarides; G Packham; A Cook; P J Farrell
Journal:  Oncogene       Date:  1991-02       Impact factor: 9.867

5.  Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.

Authors:  M Rowe; A L Lear; D Croom-Carter; A H Davies; A B Rickinson
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

6.  Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.

Authors:  K Takada; Y Ono
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

7.  Protein interaction cloning in yeast: identification of mammalian proteins that react with the leucine zipper of Jun.

Authors:  P M Chevray; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

8.  Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1.

Authors:  E Flemington; S H Speck
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

9.  IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation.

Authors:  J Auwerx; P Sassone-Corsi
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

Review 10.  The switch between EBV latency and replication.

Authors:  G Miller
Journal:  Yale J Biol Med       Date:  1989 Mar-Apr
View more
  16 in total

1.  Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.

Authors:  Takayuki Murata; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

2.  Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter.

Authors:  P Liu; S Liu; S H Speck
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter.

Authors:  S Zalani; A Coppage; E Holley-Guthrie; S Kenney
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  The Epstein-Barr virus-induced Ca2+/calmodulin-dependent kinase type IV/Gr promotes a Ca(2+)-dependent switch from latency to viral replication.

Authors:  T Chatila; N Ho; P Liu; S Liu; G Mosialos; E Kieff; S H Speck
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  EBNA2 and activated Notch induce expression of BATF.

Authors:  Lisa M Johansen; Christopher D Deppmann; Kimberly D Erickson; William F Coffin; Tina M Thornton; Sean E Humphrey; Jennifer M Martin; Elizabeth J Taparowsky
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency.

Authors:  Helen Bryant; Paul J Farrell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.

Authors:  Frederick Y Wu; Shizhen Emily Wang; Honglin Chen; Ling Wang; S Diane Hayward; Gary S Hayward
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Isolation and characterization of a novel DNA methyltransferase complex linking DNMT3B with components of the mitotic chromosome condensation machinery.

Authors:  Theresa M Geiman; Umesh T Sankpal; Andrea K Robertson; Yue Chen; Manjari Mazumdar; Jason T Heale; John A Schmiesing; Wankee Kim; Kyoko Yokomori; Yingming Zhao; Keith D Robertson
Journal:  Nucleic Acids Res       Date:  2004-05-17       Impact factor: 16.971

9.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism.

Authors:  S Zalani; E Holley-Guthrie; S Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

10.  Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.

Authors:  Shizhen Emily Wang; Frederick Y Wu; Honglin Chen; Meir Shamay; Qizhi Zheng; Gary S Hayward
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.